June 20, 2006
Surveys Show That InfoMedics' Patient Education Improves Condition Understanding and Prescription Compliance

More Than 90% of Participating Patients Reported Better Management of Side Effects when Using a Leading Prescription Drug for High Cholesterol

Philadelphia, PA – InfoMedics, Inc., the leader in patient-physician communications programs, today announced, from the DIA 42nd Annual Meeting, results from two InfoMedics treatment experience programs involving more than 9,300 physicians and 37,700 patients. As detailed in the DIA poster "Combining Education and Patient-Reported Outcomes in Patient-Physician Interventions," two separate programs were implemented in 2002 and 2003 to support physicians' efforts in educating patients with hypertension (high blood pressure) or hypercholesterolemia (high cholesterol).

Physicians identified appropriate patients to receive treatment with an antihypertensive or cholesterol-reducing medication. Patients then voluntarily elected to receive educational information about their conditions and medications through automated telephone surveys, and to respond to condition-specific questions about their understanding of the material and experience with treatment. Subsequently, the patient's prescribing physician received real-time feedback about the patient's responses in a confidential report.

"The survey data supports the use of patient education and ongoing communication between physicians and their patients as a way to improve and monitor compliance with treatment regimens," said poster co-presenter Donna Kerney, Ph.D., Director of Program Analytics at InfoMedics. "In creating patient-physician dialogue through InfoMedics programs, it is clear that patients better understand their conditions and prescriptions, which encourages stricter adherence and increased physician comfort in prescribing a specific drug."

Survey Results Highlights:

• 47% of patients were much less concerned about their blood pressure after receiving condition and medication education
• More than 95% of high cholesterol patients felt the program was helpful in educating them about how the medication improves cholesterol levels
• The majority of patients, regardless of condition, reported taking their medication "all the time as prescribed"
• Since they knew what to expect, more than 90% of high cholesterol patients felt they were better able to manage the medication's side effects

"This survey clearly demonstrates the important role education plays in effective medical care," concluded Paul LeVine, Vice President of Analytic Services at InfoMedics and poster co-presenter. "Proactively contributing to and measuring patient understanding help both patients and physicians be more comfortable with treatment regimens."

About InfoMedics
InfoMedics, Inc., headquartered in Woburn, Mass., is the only pharmaceutical services provider with a proven platform that improves the quality of the relationship between physicians and their patients; a platform designed to deliver better communications and feedback on medication satisfaction. The patient experience data delivered to physicians by InfoMedics provides specific information that benefits physicians, at the point-of-care, to optimize patient outcomes and improve compliance. InfoMedics programs facilitate the communication channel between physicians and patients around the pharmaceutical brand, enhancing product awareness and accelerating market share growth.

Founded in 1995, InfoMedics' customer base includes 14 of the world's top 15 pharmaceutical companies and multiple leading drugs by worldwide sales.

For additional information contact:
Jesse Ciccone
Matter Communications
978-499-9250 x230
jesse@matternow.com